Niacinamide and Neuroprotection: The Glaucoma Holy Grail.

J Curr Glaucoma Pract

Department of Ophthalmology, Fortis Memorial Research Institute (FMRI) Gurgaon, Haryana, India.

Published: January 2022

Bhartiya S. Niacinamide and Neuroprotection: The Glaucoma Holy Grail. J Curr Glaucoma Pract 2022;16(3):141-143.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905873PMC
http://dx.doi.org/10.5005/jp-journals-10078-1390DOI Listing

Publication Analysis

Top Keywords

niacinamide neuroprotection
8
neuroprotection glaucoma
8
glaucoma holy
8
holy grail
8
grail bhartiya
4
bhartiya niacinamide
4
grail curr
4
curr glaucoma
4
glaucoma pract
4
pract 2022163141-143
4

Similar Publications

Introduction: Depression is a prevalent and significant psychological consequence of traumatic brain injury (TBI). Ferroptosis, an iron-dependent form of regulated cell death, exacerbates the neurological damage associated with TBI. This study investigates whether nicorandil, a potassium channel opener with nitrate-like properties known for its antioxidative and neuroprotective effects, can mitigate depression-like behaviors following TBI by modulating ferroptosis.

View Article and Find Full Text PDF
Article Synopsis
  • - Zhenzhu Tongluo pills (ZZTL) have shown potential neuroprotective effects for treating neurobrucellosis (NB) in Inner Mongolia, but the specific mechanisms are not well understood.
  • - Through LC-MS analysis of cerebrospinal fluid (CSF) samples, 225 common metabolites were identified between NB patients and control subjects, with notable changes indicating dysregulation in purine metabolism and vitamin B deficiencies in NB patients that were reversed by ZZTL therapy.
  • - This study suggests that analyzing CSF metabolomics can help distinguish NB patients from healthy controls, offering useful insights for diagnosis and treatment strategies.
View Article and Find Full Text PDF

Diabetes is a multifunctional chronic disease that affects both the central and/or peripheral nervous systems. This study assessed whether nicotinamide (NAm) or conjugate of nicotinic acid with gamma-aminobutyric acid (N-GABA) could be potential neuroprotective agents against type 1 diabetes (T1D)-induced nervous system impairments in rats. After six weeks of T1D, induced by streptozotocin, nonlinear male Wistar rats were treated for two weeks with NAm (100 mg/kg, i.

View Article and Find Full Text PDF

Objective: Evaluation of the effectiveness of Cytoflavin as a neuroprotective therapy for neurological complications in premature newborns with hypoxic-ischemic encephalopathy.

Material And Methods: 56 premature newborns with low body weight were examined. Newborn children, depending on the therapy, were divided into 2 groups: Group I - 32 premature newborns with hypoxic-ischemic encephalopathy; received basic therapy and Cytoflavin; Group II - 24 premature newborns with hypoxic-ischemic encephalopathy; received only basic therapy.

View Article and Find Full Text PDF

Decreased plasma nicotinamide and altered NAD metabolism in glial cells surrounding Aβ plaques in a mouse model of Alzheimer's disease.

Neurobiol Dis

November 2024

Department of Neurogenetics, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan; Department of Experimental Gerontology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan. Electronic address:

Article Synopsis
  • Alzheimer's disease (AD) is a progressive condition leading to dementia, primarily driven by the accumulation of amyloid-β (Aβ), which causes chronic neuroinflammation and is a focal point for new treatments.
  • Recent studies highlight the importance of discovering blood-based biomarkers that reflect this neuroinflammation and could improve diagnostic methods beyond traditional approaches.
  • Analysis of plasma metabolites in a mouse model of Aβ amyloidosis revealed decreased levels of nicotinamide, suggesting that its measurement could indicate neuroinflammatory responses, making nicotinate and nicotinamide metabolism potential therapeutic targets for AD.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!